Skip to main content
Figure 3 | BMC Infectious Diseases

Figure 3

From: Cellular HIV-1 DNA levels in patients receiving antiretroviral therapy strongly correlate with therapy initiation timing but not with therapy duration

Figure 3

HIV-1 DNA levels in patients in whom the therapy was introduced before seroconversion. The relative (left) and absolute amounts (right) of HIV-1 DNA in patients in whom therapy was initiated during the chronic phase (chronic) or before seroconversion (before SC). The Wilcoxon test was used for statistical analysis.

Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us